Related by context. All words. (Click for frequent words.) 64 intravenous cyclophosphamide 61 inotropic 61 postsurgical pain 61 hepatic arterial 60 hemodynamic variables 60 ropivacaine 60 anti Xa 60 parenchymal 59 lenalidomide dexamethasone 59 Cardiopulmonary bypass 59 fibrin deposition 59 antiandrogen 59 intratumoral 59 FUSILEV enhances 59 perineural 59 antiarrhythmic 59 pharmacodynamics PD 59 isoproterenol 59 PSA nadir 59 NMDA antagonists 59 intra arterial injection 58 neutrophilic 58 bupivacaine 58 fibrinolytic 58 inotropic agents 58 Tasigna prolongs 58 intraperitoneal 58 vasodilators 58 systemic hypotension 58 tumor necrosis 58 intravesical 58 nephrotoxicity 58 intracoronary 58 intravenous heparin 58 inotropes 58 ß blockers 58 TURBT 58 postoperative morbidity 58 pseudoaneurysm 58 haemostatic 58 intra tumoral 58 PASI scores 57 cerebral perfusion 57 kg -1 57 nicardipine 57 pharmacokinetic interactions 57 hematological parameters 57 min -1 57 oral levofloxacin 57 immunosuppressive regimen 57 ureteral 57 serum phosphate levels 57 calcium antagonist 57 indinavir 57 androgen ablation 57 intradiscal 57 sonographically guided 57 venous thromboembolic disease 57 tolterodine ER 57 AST ALT 57 hepatic enzymes 57 intimal hyperplasia 57 atelectasis 57 pralidoxime 57 radiotherapy RT 57 NUCYNTA ™ 57 airway narrowing 57 intra articular 57 myelosuppressive 57 cystoscopic 57 nadolol 57 antiangiogenic agents 57 antiangiogenic 57 pyrazinamide 57 ionotropic 57 H. pylori eradication 57 neointimal 57 intravascular hemolysis 57 systemic corticosteroid 57 antiresorptive 57 immune modulating 57 conventional DMARDs 57 serum phosphorous 57 posttransplant 57 cerebral ischemia 57 certolizumab 56 primidone 56 clevidipine 56 intestinal permeability 56 Known hypersensitivity 56 analgesic medications 56 depression suicidal ideation 56 detrusor 56 preventing restenosis 56 surgical decompression 56 antirheumatic 56 antitumor effect 56 infusional 56 microbiologically evaluable 56 nonsteroidal antiinflammatory drugs 56 oral prodrug 56 antiangiogenic therapy 56 hepatic insufficiency 56 sotalol 56 myocardial contractility 56 tiagabine 56 pamidronate 56 intraluminal 56 Febrile neutropenia 56 haematologic 56 riociguat 56 arteriolar 56 antegrade cerebral perfusion 56 pulmonary capillary wedge 56 relapsed MM 56 β blockers 56 Tumor Response 56 psoriatic plaques 56 uric acid lowering 56 oral rivaroxaban 56 elevated prolactin 56 induce regression 56 omeprazole Prilosec 56 antiepileptic drugs AEDs 56 repolarization 56 inhibit platelet function 56 milrinone 56 thrombus formation 56 intra arterial 56 ureteric 56 peak plasma concentrations 56 titration phase 56 hemodynamic parameters 56 gastroduodenal 56 NUCYNTA R 56 CYP#A# substrate 56 anti resorptive 56 paroxysmal AF 56 inducible nitric oxide synthase 56 Surgical excision 56 antidepressant efficacy 56 Myriad Flurizan 56 irritative 56 hematological toxicity 56 serotonin reuptake 56 hepatic enzyme 56 aspirin clopidogrel 56 caval 56 DHCA 56 pneumonitis interstitial pneumonia 56 EGFR tyrosine kinase inhibitor 56 pulmonary artery banding 56 platelet activation 56 tibial plateau fractures 56 vasoactive 55 macrolide antibiotic 55 femoral neck fracture 55 lipid altering 55 antegrade 55 rhITF 55 biliary obstruction 55 ursodeoxycholic acid 55 prospectively stratified 55 β blocker 55 APTIVUS r 55 esophageal perforation 55 vasopressor 55 fibrinolytic therapy 55 pimozide 55 myopathy rhabdomyolysis 55 amisulpride 55 stent graft placement 55 symptomatic intracranial 55 maximal doses 55 Platelet counts 55 hypoperfusion 55 transesophageal echocardiography 55 nephrotoxic 55 arteriography 55 anticholinergic agents 55 percutaneous vertebroplasty 55 bolus injection 55 IOP lowering 55 metformin monotherapy 55 salmeterol fluticasone 55 interferon ribavirin 55 organ perfusion 55 endothelium dependent 55 LEP ETU 55 undergoing elective percutaneous 55 tipranavir r 55 neuroleptics 55 angiotensin receptor 55 corticosteroid dose 55 thrombotic complications 55 pulmonary toxicity 55 immune suppressive 55 opioid naïve 55 LHRH agonist 55 CIMZIA ™ 55 antimetabolite 55 angiotensin converting enzyme inhibitor 55 graft patency 55 remifentanil 55 transdermal estrogen 55 antitumor efficacy 55 QT interval prolongation 55 vivo potency 55 pharmacodynamic parameters 55 steroid refractory 55 intrahepatic 55 natriuresis 55 extravasation 55 Triapine R 55 radiographic findings 55 antiplatelet medications 55 TMP SMX 55 transarterial 55 GI bleeds 55 transmural 55 intralesional 55 Hypotension 55 tissue oxygenation 55 coagulopathy 55 idarubicin 55 malperfusion 55 abacavir lamivudine 55 clomipramine 55 renal allograft 55 percutaneous drainage 55 pulmonary vascular 55 POSIDUR TM 55 hepatocellular 55 postoperative chemotherapy 55 hemodynamic measurements 55 Ventavis ® 55 taxane resistant 55 amikacin 55 Erythropoietic therapies may 55 infiltration 55 pharmacologic stress 55 opioid analgesia 55 antimicrobial prophylaxis 55 postoperative AF 55 bypass grafting 55 Commonly prescribed 55 mitomycin C 55 Helicobacter pylori eradication 55 lumen diameter 55 elevated IOP 55 intact parathyroid hormone 55 gastrointestinal motility 55 thiazide diuretic 55 effector function 55 neovascularisation 55 vertebrobasilar 55 pharmacodynamic profiles 55 immune globulins 55 femoral fractures 55 vitamin B# folic acid 55 sitaxsentan 55 receiving VELCADE 55 VAPRISOL 55 Mg Usa 55 antireflux 55 immunosuppressives 55 EEG abnormalities 55 antithrombotic 55 postprocedure 55 Aggrastat ® tirofiban hydrochloride 54 treating neuropathic pain 54 adriamycin 54 glomerular filtration 54 left ventricular dysfunction 54 Adjunctive 54 arteriovenous fistula 54 intraventricular 54 demonstrated clinically meaningful 54 epidural analgesia 54 antigenicity 54 adrenal suppression 54 pleural effusions 54 extensor mechanism 54 antibody mediated 54 CYT# potent vascular disrupting 54 fibrinolysis 54 occlusive disease 54 oral antidiabetic medication 54 imatinib therapy 54 pulmonary dysfunction 54 titrated glipizide 54 achieved ACR# 54 carotid arterial 54 lymph circulation 54 cytostatic 54 GnRH agonist 54 headache abdominal pain 54 propranolol Inderal 54 intermittent hypoxia 54 submucosal 54 peripheral insulin sensitivity 54 androgen receptor signaling 54 ratio ICER 54 corticosteroid therapy 54 glycosylated hemoglobin levels 54 Serum creatinine 54 GLP1 agonist 54 hypothermic circulatory arrest 54 P selectin 54 poststroke depression 54 aminophylline 54 inflammatory cytokine 54 myocardial ischemia 54 transforaminal 54 immunomodulation 54 piperacillin tazobactam 54 hypertrophic scarring 54 retransplantation 54 extracellular dopamine 54 RVOT 54 CK # administered 54 vasodilatation 54 potentiation 54 pleural fluid 54 flutamide 54 flecainide 54 dorzolamide 54 suppressive therapy 54 plasma pharmacokinetics 54 cervical ripening 54 nonpharmacologic 54 cyclophosphamide Cytoxan 54 oxcarbazepine 54 urothelial 54 haemodynamic 54 arterial revascularization 54 PSA kinetics 54 inhaled glucocorticoids 54 cardiac repolarization 54 portal venous 54 perioperatively 54 serum PTH 54 caspofungin 54 proximal tibial 54 pharmacological therapies 54 QTc intervals 54 oral anticoagulant therapy 54 androgen therapy 54 ischemic tissues 54 postoperative bleeding 54 receiving XGEVA 54 EDARBI 54 hypomagnesemia 54 acute GvHD 54 choroidal 54 thromboembolic disease 54 jugular venous 54 ileus 54 serum lipid 54 tirofiban 54 epoprostenol 54 allograft rejection 54 Secondary endpoints include 54 Lofexidine 54 necrotic core 54 Oral corticosteroids 54 5FU 54 radicular pain 54 tumor resection 54 intermittent hemodialysis 54 factor Xa 54 headache nasopharyngitis 54 cerebral spinal 54 ostial 54 calcaneal fractures 54 neuroleptic 54 hemodynamics 54 cytoreduction 54 hemorrhagic complications 54 recurrent venous thromboembolism 54 inhaled budesonide 54 IL 1ß 54 CHOP chemotherapy 54 beta lactam antibiotic 54 basiliximab 54 tricuspid regurgitation 54 reteplase 54 mucosal inflammation 54 protein excretion 54 diuresis 54 intravesical therapy 54 PANSS scores 54 sacral neuromodulation 54 thoracolumbar spine 54 nonnucleoside reverse transcriptase inhibitors 54 graft occlusion 54 hemodilution 54 penile tissues 54 alicaforsen enema 54 neointimal hyperplasia 54 zoledronate 54 cardiopulmonary fitness 54 left ventricular diastolic 54 pyrimethamine 54 fusion enhancers 54 ketorolac 54 DMARDS 54 retinal thickness 54 cefazolin 54 eculizumab therapy 54 intranasal corticosteroids 54 somatostatin analogues 54 reintervention 54 PLX STROKE targeting 54 intrathecal 54 immunological responses 54 CorVue ™ 54 urate lowering 54 hematologic toxicity 54 reinfarction 54 Kinoid 54 d l leucovorin 54 oral anticoagulation 54 Secondary endpoints included 54 lymphadenectomy 54 ascending aortic 54 hematologic parameters 54 tibial nerve 53 pegylated interferon alfa 53 cytoprotective 53 sacral nerve stimulation 53 parenterally administered 53 captopril 53 Postoperative 53 Deep venous thrombosis 53 sustained virological response 53 labetalol 53 conjunctival injection 53 prostatic tissue 53 intracavitary 53 mecamylamine 53 periprocedural 53 antituberculosis 53 Carotid endarterectomy 53 Chemophase 53 periurethral 53 ankle arthrodesis 53 antianginal 53 oropharyngeal 53 mg hydrochlorothiazide 53 perioperative complications 53 superficial venous 53 hyperalgesia 53 doxorubicin cyclophosphamide 53 inhalational 53 pedicle screw fixation 53 hyperacute 53 antiproliferative 53 endometrial carcinoma 53 tamoxifen Nolvadex ® 53 hypervascular tumors 53 epidural anesthesia 53 Tekamlo 53 idraparinux 53 lipid lowering agents 53 neurohormonal 53 epicardial 53 stent binary restenosis 53 antiplatelet therapies 53 immunomodulatory effects 53 doxorubicin HCl 53 voriconazole 53 postoperative hemorrhage 53 hypovolemic 53 GI toxicity 53 microvessel density 53 tenecteplase 53 acute gout 53 plus prednisone prednisolone 53 clinically meaningful reductions 53 arterial grafts 53 Hypocalcemia 53 neutropenic fever 53 cardiopulmonary bypass CPB 53 fibrinolytics 53 systemic corticosteroids 53 DACH platinum 53 hypotensive 53 4mg/kg 53 saline placebo 53 aminotransferases 53 chronic GVHD 53 mucosal healing 53 saline infusion 53 seroma 53 chlamydial 53 folinic acid 53 genotypic resistance 53 ritonavir boosted 53 bronchial inflammation 53 radical prostatectomy RP 53 thrombi 53 paracentesis 53 allogeneic HSCT 53 postoperative pain 53 carotid artery blockage 53 endobronchial 53 transabdominal 53 intracranial hypertension 53 detrusor overactivity 53 ID TLR 53 myocardial perfusion 53 occlusive atherosclerotic disease 53 peritoneal fluid 53 dose cytarabine 53 imexon 53 splenic 53 lytic 53 coadministration 53 GnRH agonists 53 tissue perfusion 53 postoperative infections 53 agonist antagonist 53 hydrolytic 53 liver metastasis 53 embolic stroke 53 pharmacologic approaches 53 angina pectoris 53 neurologic outcomes 53 ventilatory 53 P = .# 53 serum HBV DNA 53 Platinol ® cisplatin 53 prilocaine 53 atorvastatin #mg 53 glycoprotein IIb IIIa inhibitor 53 nephron sparing 53 Exclusion criteria 53 lymphoproliferative disorder 53 thrombolytics 53 autoantibody levels 53 pulmonary metastases 53 arterial occlusion 53 intravenous bisphosphonates 53 edifoligide 53 Urinary tract 53 dopamine neuron 53 dysuria 53 vaginal hysterectomy 53 angioplasty stenting 53 sinus tachycardia 53 Intrathecal 53 bovine thrombin 53 intracranial hemorrhage ICH 53 expiratory 53 intraparenchymal 53 leukocytosis 53 parasitemia 53 biliary tract cancer 53 intravenous iv 53 synovial tissue 53 plasma renin activity 53 BPH benign prostatic 53 dyspnoea 53 cough dyspnea 53 osteolytic 53 diaphyseal 53 OAB symptoms 53 denervation 53 articular 53 angiotensin converting enzyme inhibitors 53 CIMZIA TM 53 dysrhythmias 53 linear pharmacokinetics 53 endoleaks 53 thrombocytopenic 53 IONSYS TM 53 CFTR function 53 steroid dexamethasone 53 hypokalemia 53 aldosterone antagonist 53 elevated creatinine 53 PEGPH# 53 NAVISTAR R 53 conventional angiography 53 OPCAB 53 trastuzumab Herceptin ® 53 polycythemia vera essential thrombocythemia 53 vasodilatory 53 non selective NMDA 53 afterload 53 thrombolytic agents 53 dose proportionality 53 bronchodilation 53 CPAP adherence 53 pyrimidine nucleoside analog 53 intima media thickness 53 serum ALT 53 valve implantation 53 tumorigenicity 53 dobutamine 53 thoracentesis 53 bronchodilatory 53 bowel resection 53 androgen suppression 53 electrical cardioversion 53 Intra articular 53 beta blockers ACE inhibitors 53 Concomitant 53 endothelial activation 53 intra articular injection 53 intensive lipid lowering 53 CsA 53 discogenic pain 53 brain parenchyma 53 octreotide 53 parkinsonian symptoms 53 arterial venous 53 KETEK 53 synovial 53 bilateral renal artery 53 tipranavir 53 baroreflex sensitivity 53 dual antiplatelet 53 antiarrhythmic drugs 53 plus methotrexate 53 nephrectomies 53 pharmacodynamic PD 53 immunosuppressive agents 53 cervicitis 53 antiemetics 53 urography 53 retropubic 53 transurethral resection 53 potassium sparing 53 distensibility 52 gemifloxacin 52 adrenalectomy 52 intracellular uptake 52 coronary perfusion 52 antioxidant supplementation 52 renoprotective 52 radiopacity 52 anaphylactic reactions bronchospasm 52 rt PA 52 chemosensitivity 52 cisplatin gemcitabine 52 balloon valvuloplasty 52 ablative therapy 52 MAGE A3 ASCI 52 nonhematologic adverse reactions 52 either acutely decompensated 52 LNG IUS 52 trabeculectomy 52 intravenous subcutaneous 52 pharmacologic 52 cobiprostone 52 vasomotor 52 prostatic 52 CYP#D# inhibitor 52 anticholinergic medication 52 S. aureus colonization 52 endocardial 52 EDEMA3 trial 52 N acetyl cysteine 52 psychosocial variables 52 inhibitory effects 52 Vincristine 52 Thrombotic thromboembolic complications 52 endogenous EPO 52 mediastinal 52 intraarticular 52 thrombosed 52 TNF alpha inhibitor 52 morphometric vertebral fractures 52 stented artery 52 LHRH analogues 52 myocardial dysfunction 52 TNF alpha antagonist 52 hyperphenylalaninemia HPA due 52 enzymatic degradation 52 SSRI SNRI 52 peritoneal 52 factor PlGF 52 CR nPR 52 busulfan 52 systemic immunosuppressive drugs 52 Benazepril 52 cannulation 52 C1 INH deficiency 52 mycophenolate 52 zotarolimus 52 anastomotic 52 acetazolamide 52 CINQUIL 52 chronicity 52 antiinflammatory 52 transurethral 52 vasopressors 52 NATRECOR ® 52 neuroinflammatory 52 Gleevec resistant 52 nausea constipation 52 empiric therapy 52 alanine aminotransferase 52 gp# vaccine 52 pharmacokinetic parameters 52 coronary bypass graft 52 vagal 52 headache nausea diarrhea 52 nonoperative treatment 52 anemia thrombocytopenia 52 myocardial oxygen 52 electroacupuncture 52 % CI #.#-#.# [008] 52 concomitant medications 52 Vidofludimus 52 contractile function 52 granisetron 52 lymph drainage 52 antifibrotic 52 thromboprophylaxis 52 methotrexate therapy 52 anastomotic leak 52 inhibits platelet aggregation 52 renal toxicity 52 #mg BID [001] 52 trials RCTs 52 p = NS 52 MCyR 52 inhibit tumor angiogenesis 52 ventricular dilatation 52 Inhaled steroids 52 adrenocorticotropic hormone ACTH 52 aliskiren amlodipine 52 percutaneous tibial nerve 52 antiplatelets 52 osteoarthritic 52 fatty infiltration 52 vasoconstrictor 52 chlorpromazine 52 postoperative inflammation 52 primary spontaneous pneumothorax 52 severe hypersensitivity reactions 52 Zollinger Ellison Syndrome 52 Proellex TM 52 recovery CRp 52 superficial femoral 52 lowering blood glucose 52 Cardiotoxicity 52 PV module efficiencies 52 danazol 52 Methotrexate MTX 52 gastrointestinal absorption 52 divalproex sodium 52 IIIa inhibitor 52 analgesic efficacy 52 kidney urologic 52 liposomes containing 52 shortens systolic ejection 52 IV bolus 52 weekly subcutaneous injections 52 containing abacavir 52 systemic immunosuppressive 52 acromioclavicular 52 tortuosity 52 Postoperatively 52 cyclooxygenase 2 52 enteric coated aspirin 52 paralytic ileus 52 esophageal gastric 52 gut mucosa 52 hepatic cirrhosis 52 calcified lesions 52 dose atorvastatin 52 dose dependently 52 subclinical cardiovascular disease 52 overt nephropathy 52 catheter occlusion 52 methylprednisolone 52 serum potassium 52 APTIVUS ritonavir 52 balloon dilatation 52 Losartan 52 prednisone prednisolone 52 C telopeptide 52 response CCyR 52 INTEGRILIN R 52 transthoracic 52 viral kinetics 52 antiarrhythmics 52 myocardial function 52 Primary endpoints 52 loop diuretic 52 severe hepatic dysfunction 52 octreotide LAR 52 pramlintide metreleptin combination 52 MoxDuo TM IR 52 exogenous insulin 52 tumor lysis syndrome 52 hsCRP levels 52 AtuPLEX 52 prazosin 52 Bacillus Calmette Guerin BCG 52 HMG CoA reductase inhibitors 52 cardiovascular calcification 52 endometrial thickness 52 inspiratory 52 adrenocortical 52 subacromial 52 hemoptysis 52 avosentan 52 hemostatic efficacy 52 unblock clogged arteries 52 Antihypertensive 52 DuraSite ® 52 reimplantation 52 pegnivacogin 52 brand ciclesonide HFA 52 terazosin 52 paroxysmal supraventricular tachycardia 52 induced neurotoxicity 52 serum magnesium 52 acetylcysteine 52 Central Venous Catheter 52 symptomatic hyponatremia 52 opiate analgesics 52 incisional 52 quetiapine XR 52 Carotid artery 52 efficacy tolerability 52 Intracoronary 52 hydronephrosis 52 electrolyte abnormalities 52 Project SCIP 52 dissolving clots 52 nausea emesis 52 skeletal metastases 52 adjunctively 52 cholestyramine 52 AGILECT R 52 acromegalic patients 52 comorbid depression 52 acute ischemia 52 mitral stenosis 52 Tranexamic acid 52 mometasone 52 ULORIC 52 vincristine 52 paroxysmal atrial fibrillation 52 inhaled iloprost 52 γ secretase 52 SCr 52 pathway inhibitor 52 orthostatic blood 52 plasminogen activators 52 beta adrenergic receptor 52 controlled analgesia PCA 52 dural 52 pharmacodynamic effects 52 NIASPAN 52 adjunctive therapies 52 myoma 52 quinidine 52 solubilization 52 coronary stenosis 52 surgical debulking 52 NUCYNTA TM 52 bolus dose 52 esomeprazole 52 maximal tolerated 52 cortical excitability 52 Zemplar Capsules 52 tapentadol ER 52 oral vancomycin 52 extravascular 52 Diovan HCT 52 distal anastomosis 52 platelet inhibitor 52 vecuronium 52 cytolytic 52 liver transaminases 52 LHRH antagonists 52 anti androgen 52 perioperative mortality 52 venography 52 nasopharyngitis headache 52 gastrointestinal perforation 52 transaminase elevations 52 vessel constriction 52 ischemic mitral regurgitation 52 FRAGMIN R 52 potassium sparing diuretics 52 #beta estradiol 51 neutropenia thrombocytopenia 51 trans urethral resection 51 neostigmine 51 dose titration 51 pulmonary arterial 51 clonidine hydrochloride 51 Histologic 51 ATACAND 51 topical NSAIDs 51 Adverse effects 51 baseline LDH 51 pharmacologic therapies 51 myometrium 51 buprenorphine naloxone 51 autoregulation 51 coronary vasodilation 51 anastomotic devices 51 sub maximal 51 elevated transaminases 51 ICSs 51 serum urate 51 prospectively defined 51 neutrophil counts 51 vitreous floaters 51 CVT E# 51 AERx ® 51 wound dehiscence 51 Rimantadine 51 urodynamic parameters 51 Lymph node 51 resorption 51 androgen hormone 51 somatostatin analog 51 alpha adrenergic 51 esophageal strictures 51 mediated inhibition 51 capillary density 51 CYP #A# 51 hypoxemia 51 thrombectomy 51 ischemia induced 51 peri procedural 51 renal tubular 51 leukotriene receptor antagonist 51 bony metastases 51 ergot alkaloids 51 thrombophlebitis 51 cerebral oxygenation 51 pulse amplitude 51 Duodenal 51 pulmonary inflammation 51 serum bicarbonate 51 arsenic trioxide ATO 51 atherothrombotic 51 rituximab monotherapy 51 peg interferon 51 opacification 51 AMPYRA doses 51 raloxifene Evista 51 Chk1 inhibitors 51 coagulation abnormalities 51 IFN alfa 51 underwent angiography 51 capillary leakage 51 bronchial hyperresponsiveness 51 Parkinsonian symptoms 51 mutant enzymes 51 expiratory pressure 51 serum IgG 51 anti tubercular 51 symptom flare ups 51 primary aldosteronism 51 Bcr Abl mutations 51 lamivudine refractory patients 51 MYLOTARG 51 BEXXAR Therapeutic Regimen 51 induce remission 51 prostaglandin E1 51 symptomatic paroxysmal AF 51 peroneal 51 desvenlafaxine succinate 51 arterial stiffening 51 talar 51 NATRECOR R 51 BRAF inhibitors 51 intravenous morphine 51 rhTSH 51 temporal lobectomy 51 periosteal 51 Decadron 51 antifibrinolytic agents 51 crossclamp 51 cerebral ischemic 51 osteoconductive 51 minimal invasiveness 51 antiarrhythmic drug 51 oral antidiabetes 51 pharmacodynamic endpoints 51 hydroxymethyl coenzyme 51 somatosensory evoked potentials 51 submandibular gland 51 hyperemia 51 extrapyramidal side 51 phenelzine 51 Cyclosporine